A Single-blind, Placebo-controlled, Outpatient Trial to Assess the Effects of Single Oral Tablet Dose of OPC-214870
Clinical trial NCT04241965 · COMPLETED
Trial details
- NCT number
- NCT04241965
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-18
- Primary completion
- 2021-10-11
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.